The dosimetry of brachytherapy-induced erectile dysfunction

Medical Dosimetry

Volumn 28, Issue 4, 2003, Pages 271-274

  Merrick, Gregory S ^a   Butler, Wayne M ^b  

^a WHEELING HOSPITAL   (United States)

^b NONE

Author keywords

Brachytherapy; Dosimetry; Erectile dysfunction; Prostate; Quality of life

Indexed keywords

ISOTOPE;

BEAM THERAPY; BRACHYTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CORRELATION ANALYSIS; DOSIMETRY; ERECTILE DYSFUNCTION; HUMAN; INNERVATION; MEDLINE; PENILE BLOOD VESSEL; PENIS; PRIORITY JOURNAL; PROSTATE; PROSTATECTOMY; RADIATION DOSE; RADIATION SICKNESS; REVIEW; TECHNIQUE; TREATMENT PLANNING;

EID: 0347479354     PISSN: 09583947     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.meddos.2003.10.001     Document Type: Article

References (20)

1. Merrick G.S., Wallner K.E., Butler W.M. Management of sexual dysfunction after prostate brachytherapy. Oncology. 17:2003;52-62.
2. Litwin M.S., Lubeck D.P., Henning J.M., et al. Differences in urologist and patient assessments of health related quality of life in men with prostate cancer Results of the CaPSURE database . J. Urol. 159:1998;1988-1992.
3. Zelefsky M.J., Eid J.F. Elucidating the etiology of erectile dysfunction after definitive therapy for prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 40:1998;129-133.
4. Stock R.G., Kao J., Stone N.N. Penile erectile function after permanent radioactive seed implantation for treatment of prostate cancer. J. Urol. 165:2001;436-439.
5. Merrick G.S., Butler W.M., Galbreath R.W., et al. Erectile function after permanent prostate brachytherapy. Int. J. Radiat. Oncol. Biol. Phys. 52:2002;893-902.
6. Lepor H., Gregerman M., Crosby R., et al. Precise localization of the autonomic nerves from the pelvic plexus to the corpora cavernosa A detailed anatomical study of the adult male pelvis . J. Urol. 133:1985;207-212.
7. DiBiase S.J., Wallner K., Tralins K., et al. Brachytherapy radiation doses to the neurovascular bundles. Int. J. Radiat. Oncol. Biol. Phys. 46:2000;1069-1074.
8. Merrick G.S., Wallner K., Butler W.M., et al. Short-term sexual function after prostate brachytherapy. Int. J. Cancer (Radiat. Oncol. Invest.). 96:2001;313-319.
9. Merrick G.S., Butler W.M., Dorsey A.T., et al. A comparison of the radiation dose to the neurovascular bundles in men with and without prostate brachytherapy induced erectile dysfunction. Int. J. Radiat. Oncol. Biol. Phys. 46:2000;1069-1074.
10. Carrier S., Hricak H., Lee S., et al. Radiation-induced decrease in nitric oxide synthase-containing nerves in the rat penis. Radiology. 195:1995;95-99.
11. Pickett B., Fisch B.M., Weinberg V., et al. Dose to the bulb of the penis is associated with the risk of impotence following radiotherapy for prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 45:1999;263.
12. Fisch B.M., Pickett B., Weinberg V., et al. Dose of radiation received by the bulb of the penis correlates with risk of impotence after three-dimensional conformal radiotherapy for prostate cancer. Urology. 57:2001;955-959.
13. Merrick G.S., Wallner K., Butler W.M., et al. A comparison of radiation dose to the bulb of the penis in men with and without prostate brachytherapy induced erectile dysfunction. Int. J. Radiat. Oncol. Biol. Phys. 50:2001;597-604.
14. Wallner K., Merrick G.S., Benson M., et al. Penile bulb imaging. Int. J. Radiat. Oncol. Biol. Phys. 53:2002;928-933.
15. Merrick G.S., Butler W.M., Wallner K., et al. The importance of radiation doses to the penile bulb versus crura in the development of postbrachytherapy erectile dysfunction. Int. J. Radiat. Oncol. Biol. Phys. 54:2002;1055-1062.
16. Mulhall J.P. Minimizing radiation-induced erectile dysfunction. J. Brachytherapy Int. 17:2001;221-227.
17. Mulhall J.P., Yonover P., Sethi A., et al. Radiation exposure to the corporeal bodies during 3-dimensional conformal radiation therapy for prostate cancer. J. Urol. 167:2002;539-542.
18. Mulhall J.P., Yonover P. Correlation of radiation dose and impotence risk after three-dimensional conformal radiotherapy for prostate cancer. Urology. 58:2001;828.
19. Potters L., Torre T., Fearn P.A., et al. Potency after permanent prostate brachytherapy for localized prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 50:2001;1235-1242.
20. Wallner K., Merrick G.M., True L., et al. I-125 versus Pd-103 for low risk prostate cancer Morbidity outcomes from a prospective randomized multicenter trial. Cancer J. 8:2002;67-73.